CVS Health Corporation (CVS) - 2024 Annual Report (10-K) Summary
Business Context and Reporting Period
This summary covers the fiscal year ended December 31, 2024. CVS Health operates as a leading health solutions company with four reportable segments: Health Care Benefits (insurance products), Health Services (PBM and care delivery), Pharmacy & Consumer Wellness (retail pharmacies and front store), and Corporate/Other. As of year-end, the company operated over 9,000 retail locations, served approximately 90 million PBM plan members, and covered an estimated 36 million people through health insurance products.
Key Financial Metrics (2024 vs. 2023)
| Metric | 2024 | 2023 | Change |
|---|---|---|---|
| Total Revenues | $372.8 billion | $357.8 billion | +4.2% |
| Operating Income | $8.5 billion | $13.7 billion | -38.0% |
| Net Income (Attributable to CVS) | $4.6 billion | $8.3 billion | -44.7% |
| Diluted EPS | $3.66 | $6.47 | -43.4% |
| Operating Cash Flow | $9.1 billion | $13.4 billion | -32.2% |
| Adjusted Operating Income | $12.0 billion | $17.5 billion | -31.7% |
Segment Performance:
- Health Care Benefits: Revenues increased 23.7% to $130.7 billion, but the segment reported an operating loss of $0.98 billion (down from $3.9 billion income) due to elevated medical utilization and a Medical Benefit Ratio (MBR) of 92.5%.
- Health Services: Revenues decreased 7.1% to $173.6 billion, primarily due to the loss of a large client and price improvements. Operating income remained relatively flat at $6.9 billion.
- Pharmacy & Consumer Wellness: Revenues increased 6.6% to $124.5 billion. Operating income declined 10.8% to $4.8 billion, impacted by pharmacy reimbursement pressure and front store volume declines.
Material Changes and Drivers
- Elevated Medical Utilization: The primary driver of the decline in profitability was higher-than-expected medical utilization in the Health Care Benefits segment, particularly in Medicare Advantage and Medicaid lines, following the resumption of member redeterminations.
- Restructuring Charges: The company recorded $1.2 billion in restructuring charges in 2024, including a $607 million store impairment charge related to the planned closure of 271 retail stores in 2025 and corporate workforce optimization.
- PBM Pricing Pressure: The Health Services segment faced continued pressure to share a larger portion of manufacturer rebates with clients and limitations on "spread pricing" models.
- Debt Management: The company recognized a $491 million gain on the early extinguishment of debt after repaying approximately $2.6 billion of senior notes in December 2024.
Guidance, Outlook, and Risks
2025 Outlook: Management expects continued pressure from elevated medical utilization in the Health Care Benefits segment and health care delivery assets. The company anticipates medical membership declines in Medicare and individual exchange products. While the company expects benefits from cost-saving initiatives (targeting over $500 million in savings in 2025), it warns that utilization beyond projections could necessitate further premium deficiency reserves.
Key Risks and Contingencies:
- Regulatory Scrutiny: Significant exposure to changes in Medicare and Medicaid reimbursement rates, risk adjustment methodologies (RADV audits), and PBM regulations. The FTC has filed an administrative complaint regarding PBM practices.
- Credit Ratings: In December 2024, Moody's downgraded the company's long-term debt rating to "Baa3" (investment grade) with a stable outlook. Fitch initiated coverage with a "BBB" rating and a negative outlook.
- Legal Proceedings: Ongoing litigation includes opioid settlement obligations, PBM pricing investigations, and controlled substance allegations. The company has accrued liabilities but notes the ultimate loss may differ.
- Store Optimization: The company plans to close 271 additional retail stores in 2025 as part of its footprint optimization strategy.
Investor Verification Checklist
- Medical Benefit Ratio (MBR) Trends: Verify if the 92.5% MBR in Health Care Benefits stabilizes in 2025 or if further premium deficiency reserves are required.
- Store Closure Execution: Monitor the progress of the 271 store closures planned for 2025 and the associated impairment charges.
- Credit Rating Trajectory: Track credit rating agency actions (Moody's, Fitch, S&P) given the recent downgrades and negative outlooks, which impact borrowing costs.
- PBM Regulatory Outcomes: Assess the impact of the FTC complaint and state-level PBM legislation on the Health Services segment's revenue model.
- Medicare Star Ratings: Confirm the 2025 star ratings (88% of members in 4+ star plans) and their impact on 2026 bonus payments.